Media

Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

Tribune Therapeutics announces new CMC collaboration

Information regarding Oncopeptides’ appeal of U.S. withdrawal published

Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman

Vicore Pharma Holding AB: Interim report April-June 2023

Vicore reports data from EndoPAT® exploratory trial

Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Oncopeptides publishes Q2 report 2023